Paper Review Records
All Paper Review Records
5 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
322
days
Mindfulness and Tai Chi for Sleep, Fatigue, and Pain in Distressed People After Cancer Treatment: A Partially Randomized Patient-Preference Comparative Effectiveness Trial
Authors
Yan Ma; Linda E. Carlson; Jennifer M. Jones; Oluwaseyi A. Lawal; Devesh Oberoi; Katherine-Ann Piedalue; Daniel Santa Mina; Michael Speca; Peter M. WayneShow moreShow less
Affiliations
1. Osher Center for Integrative Health, Harvard Medical School and Brigham and Women's Hospital, Boston, MA; 2. Department of Oncology, University of Calgary, Calgary, AB, Canada; 3. Department of Supportive Care, Princess Margaret Cancer Centre, Toronto, ON, CanadaShow moreShow less
193
days
Molecularly Guided Therapy Versus Continued Chemotherapy in Unfavorable Cancer of Unknown Primary: Updated Efficacy and Safety From the Randomized, Phase II CUPISCO Study
Authors
Alwin Krämer; Tilmann Bochtler; Chantal Pauli; Kai-Keen Shiu; Natalie Cook; Juliana Janoski de Menezes; Roberto A. Pazo-Cid; Ferran Losa; Debbie G.J. Robbrecht; Jiří Tomášek; Cagatay Arslan; Mustafa Özgüroğlu; Panoraia Arni; Frederic Bigot; Sun Young Kim; Yoichi Naito; Antoine Italiano; Nasséra Chalabi; Gonzalo Durán-Pacheco; Ning Ma; Jeremy Scarato; Jeffrey S. Ross; Holger Moch; Linda MileshkinShow moreShow less
Affiliations
1. Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 2. Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany; 3. Department of Medical Oncology, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany; 4. Department of Pathology and Molecular Pathology, University Hospital Zürich, Zürich, Switzerland; 5. Medical Faculty, University of Zürich, Zürich, Switzerland; 6. UCLH Gastrointestinal Oncology Service, Cancer of Unknown Primary Service, UCL Cancer Institute, London, United Kingdom; 7. The Christie NHS Foundation Trust, Manchester, United Kingdom; 8. Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom; 9. Clinical Oncology, Centro Pesquisa Integrado em Oncologia, Porto Alegre, Brazil; 10. Medical Oncology Department, Miguel Servet University Hospital, Zaragoza, Spain; 11. Medical Oncology Department, Hospital de Sant Joan Despí Moisès Broggi, ICO L'Hospitalet, Barcelona, Spain; 12. Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands; 13. Department of Complex Oncology Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic; 14. İzmir University of Economics, Medical Point Hospital, İzmir, Türkiye; 15. Department of Internal Medicine, Division of Medical Oncology, Cerrahpasa Faculty of Medicine, Istanbul University Cerrahpasa, Istanbul, Türkiye; 16. Department of Medical Oncology, Evang. Kliniken Essen-Mitte, Essen, Germany; 17. Department of Medical Oncology, European Interbalkan Medical Center, Thessaloniki, Greece; 18. Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Angers, France; 19. Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; 20. Department of General Internal Medicine, National Cancer Center Hospital East, Kashiwa, Japan; 21. Department of Medicine, Institut Bergonié, Bordeaux, France; 22. University of Bordeaux, Bordeaux, France; 23. Global Product Development Medical Affairs, F. Hoffmann-La Roche Ltd, Basel, Switzerland; 24. Global Product Development Data and Statistical Sciences, F. Hoffmann-La Roche Ltd, Basel, Switzerland; 25. Late-Stage and Marketed Medicines Safety, Product Development Safety, Genentech, Inc, South San Francisco, CA; 26. Clinical Development and Medical Affairs, Roche Diagnostics, F. Hoffmann-La Roche Ltd, Basel, Switzerland; 27. Pathology Group, Foundation Medicine, Inc, Cambridge, MA;; 28. Department of Pathology, Upstate Medical University, Syracuse, NY; 29. Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, AustraliaShow moreShow less
148
days
Refined Continuous Risk Index for Accurately Predicting Outcomes of Patients With Chronic Lymphocytic Leukemia After Limited-Duration Therapy
Authors
Othman Al-Sawaf; Can Zhang; Mohammad S. Esfahani; Chih Long Liu; Sandra Robrecht; Eugen Tausch; Anke Schilhabel; Matthias Ritgen; Christof Schneider; Martin Peifer; Moritz Fürstenau; Carsten Utoft Niemann; Arnon P. Kater; John F. Seymour; Brenda Chyla; Yanwen Jiang; Barbara Eichhorst; Stephan Stilgenbauer; Michael Hallek; Ash A. Alizadeh; David M. Kurtz; Kirsten FischerShow moreShow less
Affiliations
1. Department I of Internal Medicine and Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; 2. Divisions of Oncology & Hematology, Department of Medicine, Stanford University, Stanford, CA; 3. Division of CLL, Department III of Internal Medicine, Ulm University, Ulm, Germany; 4. Department II of Internal Medicine, Campus Kiel, University of Schleswig-Holstein, Kiel, Germany; 5. University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Translational Genomics, Cologne, Germany; 6. Rigshospitalet, Copenhagen, Denmark; 7. Danish Cancer Institute, Copenhagen, Denmark; 8. Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands; 9. Department of Hematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia; 10. AbbVie Inc, North Chicago, IL; 11. Genentech, South San Francisco, CAShow moreShow less
136
days
Omitting Bone Marrow Sampling in FDG-Avid Rhabdomyosarcoma With 2-[18F]FDG PET-Negative Marrow: Results From an International Retrospective Study
Authors
Federico Mercolini; Marissa Just; Barry L. Shulkin; Natalie B. Collins; Jacquelyn Crane; Douglas Harrison; Maria C. Affinita; Wendy Allen-Rhoades; Alessandra Alessi; Sebastian D. Asaftei; Michael A. Arnold; Sonja Chen; Stefano Chiaravalli; Forrest FitzGerald; Martin T. Freitag; Jessica L. Iftner; Hedieh Khalatbari; Bart de Keizer; Irene von Luettichau; Christine Mauz-Körholz; Claudia Rossig; Guido Rovera; Stefan Rutkowski; Justin B. Sims; Stephan D. Voss; Ayami Yoshimi; Suzi Birz; Gianni Bisogno; Martin Ebinger; Johannes H.M. Merks; Monika Sparber-Sauer; Bernhard Haller; Aaron R. Weiss; Corinne M. Linardic; Reineke A. Schoot; Simone Hettmer; for the INSTRuCT Imaging/Pathology/Biology Network INSTRuCT Imaging/Pathology/Biology NetworkBaldariGiorgioBorrego-DoradoIsabelBaffaNicodemoCaldarellaCarmeloCheesmanEdmundDegitzCarmenDiGianvittorioMichaelFantiStefanoFischerAlexandraFoxJosef J.Arturo FusoGiuseppeHiemcke-JiwaLauraHeinzelAlexanderJacobSebastianKleinwechterMarthaKröningPiaLohrmannChristianMoraniAjaykumar C.NadelHelenParisiMarguerite T.PerruccioKatiaPuglianoMartinaFontCarlos RamosCuomoMaria RosariaRuffiniLiviaSaabRayaScarlatteiMauraSchäferJürgenSchachtrupKristinaSternbergMicheleUhlMarkusVerberneHein J.ZucchettaPietroShow moreShow less
Affiliations
1. Pediatric Hematology and Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; 2. Department of Pediatric Hematology/Oncology/Stem Cell Transplant, Indiana University, Indianapolis, IN; 3. Department of Radiology, St Jude Children's Research Hospital, Memphis, TN; 4. Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA; 5. Pediatric Hematology/ Oncology/ Stem Cell Transplantation and Regenerative Medicine, Stanford Medicine, Stanford, CA; 6. Pediatric Oncology, Children's Hospital of Philadelphia, Philadelphia, PA; 7. Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX; 8. Nemours Childrens Health and Sidney Kimmel Medical College of Thomas Jefferson University, Delaware Valley, DE; 9. Pediatric Hematology Oncology Division, University Hospital of Padua, Padua, Italy; 10. Mayo Clinic Comprehensive Cancer Center, Rochester, MN; 11. Nuclear Medicine, IRCCS Foundation, National Institute of Tumor, Milan, Italy; 12. Department of Pediatric Hematology and Oncology, University Children's Hospital “Regina Margherita”, Turin, Italy; 13. Department of Pathology and Laboratory Medicine, Children's Hospital Colorado and Department of Pathology, University of Colorado, Aurora, CO; 14. Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, OH; 15. Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; 16. Massachusetts Institute of Technology, Cambridge, MA; 17. Department of Nuclear Medicine, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; 18. Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Children's Hospital, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; 19. Texas Scottish Rite Hospital for Children, Dallas, TX; 20. Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; 21. Department of Pediatrics, Children's Cancer Research Center, Kinderklinik München Schwabing, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany; 22. Department of Pediatric Hematology, Oncology and Immunodeficiencies, Justus-Liebig-University, Gießen, Germany; 23. Medical Faculty, Martin Luther University Halle-Wittenberg, Halle, Germany; 24. University Children's Hospital Muenster, Muenster, Germany; 25. Department of Medical Sciences, University of Turin, Turin, Italy; 26. Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 27. Department of Radiology, Indiana University, Indianapolis, IN; 28. Department of Radiology, Children's Hospital Boston and Harvard Medical School, Boston, MA; 29. Department of Pediatrics, University of Chicago, Chicago, IL; 30. Department of Women's and Children's Health, University of Padua, Padua, Italy; 31. Department of Pediatric Hematology and Oncology, University Children's Hospital, Tübingen, Germany; 32. Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; 33. Stuttgart Cancer Center, Zentrum für Kinder-, Jugend- und Frauenmedizin, Stuttgart, Germany; 34. Institute of AI and Informatics in Medicine, TUM School of Medicine and Health, Technical University München, München, Germany; 35. MaineHealth Maine Medical Center, Portland, ME; 36. Departments of Pediatrics and Pharmacology & Cancer Biology, Duke University School of Medicine, Durham, NC; 37. Department of Pediatric Hematology and Oncology, Martin Luther University Halle-Wittenberg, Halle, GermanyShow moreShow less
237
days
Laser Interstitial Thermal Therapy for Brain Tumors: A Prospective Multicenter Analysis of Patients From the LAANTERN Study
Authors
Eric C. Leuthardt; Veronica Chiang; Constantinos G. Hadjipanayis; Patrick Landazuri; Dimitris G. Placantonakis; Steven R. Abram; David A. Sun; Kris A. Smith; Alireza M. Mohammadi; Clark C. Chen; Brian J. Williams; David E. Piccioni; Tiffany R. Hodges; Andrew E. Sloan; Bradley Lega; Analiz Rodriguez; Michel Lacroix; Fedor Panov; Hamid Borghei Razavi; James Baumgartner; Taylor J. Abel; Kathleen Bandt; Matthew D. Smyth; Ganesh Rao; Peter E. Fecci; Adrian W. Laxton; Stephen B. Tatter; Albert H. Kim; Sujit S. PrabhuShow moreShow less
Affiliations
1. Department of Neurosurgery, Washington University, St Louis, MO; 2. Department of Neurosurgery, Yale University, New Haven, CT; 3. Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA; 4. Department of Neurology, University of Kansas Medical Center, Kansas City, KS; 5. Department of Neurosurgery, NYU Grossman School of Medicine, New York, NY; 6. Ascension St Thomas Brain and Spine Tumor Center, Howell Allen Clinic, Nashville, TN; 7. Norton Neuroscience Institute, Norton Health Care, Louisville, KY; 8. Barrow Neurological Institute, Phoenix, AZ; 9. Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, OH; 10. Department of Neurosurgery, Brown University, Providence, RI; 11. Brain & Spine Institute, University of Louisville Health, Louisville, KY; 12. Department of Neurosciences, University of California San Diego School of Medicine, San Diego, CA; 13. Brain Tumor and Neuro-Oncology Center, University Hospitals Cleveland Medical Center, Cleveland, OH; 14. Division of Neurosurgery, Neuroscience Institute, Premier Health & Wright State University School of Medicine, Dayton, OH; 15. Department of Neurosurgery, Peter O'Donnell Brain Institute, University of Texas Southwestern Medical Center, Dallas, TX; 16. Department of Neurosurgery, University of Arkansas for Medical Sciences, Little Rock, AR; 17. Department of Neurosurgery, Geisinger Neuroscience Institute, Danville, PA; 18. Department of Neurosurgery, Mount Sinai, New York, NY; 19. Department of Neurosurgery, Cleveland Clinic, Weston, FL; 20. Department of Neurosurgery, Florida Hospital Advent Health, Orlando, FL; 21. Department of Neurological Surgery, Northwestern University, Chicago, IL; 22. Department of Neurological Surgery, Johns Hopkins All Children's Hospital, St Petersburg, FL; 23. Department of Neurosurgery, Baylor College of Medicine, Houston, TX; 24. Department of Neurosurgery, University of Colorado School of Medicine, Aurora, CO; 25. Department of Neurosurgery, Wake Forest University School of Medicine, Winston-Salem, NC; 26. Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TXShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days